iTeos Therapeutics, Inc.

NASDAQ:ITOS

8.97 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -7.128-38.216-30.551-32.24-34.3-15.55120.4530.9915.62669.582184.87269.642-26.459-13.534-14.904-10.68-7.202-5.247-5.376-6.921-5.755-4.402
Depreciation & Amortization 0.3090.3030.2270.2240.2250.2220.2230.2050.1950.180.1510.1760.150.1260.1430.1420.1290.1210.1460.1580.1580.149
Deferred Income Tax 00000000000000000-1.265-0.9530.230.488-0.784
Stock Based Compensation 8.0627.2637.1937.0576.9645.8075.8855.7235.764.1934.0413.9423.2272.5842.0421.7140.350.1860.20.2010.2030.205
Change In Working Capital -32.380.9911.552-6.2690.101-14.183-52.009-36.618-41.905-97.959-247.882531.2394.825-3.9727.279-1.41-3.2776.738-0.9580.791-0.9340.019
Accounts Receivables -37.3460.384-2.2660.026-0.6990.5545.231-0.869-0.5790.2051.681-0.913-3.154-0.95800000000
Change In Inventory 002.266-0.0260.699-0.554-5.2310.8690.5790000000000000
Change In Accounts Payables 5.333-5.5517.617-2.069-0.408-2.104-2.642-1.0440.9825.4650.517-6.5025.9172.3480.776-0.154-2.2943.3490.253-0.916-0.3690.877
Other Working Capital -0.3676.1573.935-4.20.509-12.079-49.367-35.574-42.887-103.424-248.399537.741-1.092-6.326.503-1.256-0.9833.389-1.2111.707-0.565-0.858
Other Non Cash Items 37.90310.296-2.186-2.662-2.536-2.85-1.7250.0030.0020.0020.0020.0020.0020.006-0.0240.003-0.002-0.012-0.002-0.003-0.003-0.002
Operating Cash Flow -33.927-32.4-13.765-33.89-29.546-26.555-27.173-29.696-30.322-24.002-58.816605.001-18.255-14.79-5.464-10.231-10.0020.521-6.943-5.544-5.843-4.815
Investing Activities:
Investments In Property Plant And Equipment -0.442-0.945-1.396-0.751-0.7-0.119-0.117-0.083-0.511-0.227-0.162-0.53-0.401-0.088-0.134-0.103-0.092-0.0270.016-0.064-0.142-0.531
Acquisitions Net 00-10.7720-20.80331.5750000000000000000
Purchases Of Investments -89.221-155.852-97.031-54.473-86.462-52.575-0.445000000000000000
Sales Maturities Of Investments 105.98587.197159.99978107.265210000000000000000
Other Investing Activites 0-6.065-0.016-0.08320.803-31.575-444.558-0.022-0.003-0.0960.001-0.002-0.057-0.0030-0.002-0.009-0.01-0.06-0.024-0.035-0.086
Investing Cash Flow 16.322-69.661.55622.69320.103-31.694-445.12-0.105-0.514-0.323-0.161-0.532-0.458-0.091-0.134-0.105-0.101-0.037-0.044-0.088-0.177-0.617
Financing Activities:
Debt Repayment 0000000000000000000000
Common Stock Issued 122.3760.0220.3070.010.2180.5780.925-0.0010.2780.3332.9430.4410.1950.667125.3580000000
Common Stock Repurchased 0000000-0.0010000000.33200-0.3320000
Dividends Paid 0000000000000000000000
Other Financing Activities 122.3760.0220.3070.010.2180.5780.4490.0010.2780.333-0.5870.4410.1950.667-124.857212.873-1.106128.07100.06522.4740
Financing Cash Flow 122.3760.0220.3070.010.2180.5781.374-0.0010.2780.3332.3560.4410.1950.6670.833212.873-1.106127.73900.06522.4740
Other Information:
Effect Of Forex Changes On Cash -0.289-2.554-1.048-0.8950.112-1.7713.488-9.88-1.571-0.5635.552-8.0780.067-0.7171.1120.5770.349-0.360.633-1.3490.591-0.407
Net Change In Cash 104.45-104.52947.05-12.082-9.113-59.442-467.431-39.682-32.129-24.555-51.069596.832-18.451-14.931-3.653203.114-10.86127.863-6.354-6.91617.045-5.839
Cash At End Of Period 251.098146.648251.451204.401216.483225.596285.038752.469792.151824.28848.835899.904303.072321.523336.454340.107136.993147.85319.9926.34433.2616.215